Entao Li

1.4k total citations
54 papers, 742 citations indexed

About

Entao Li is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Entao Li has authored 54 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 13 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Entao Li's work include SARS-CoV-2 and COVID-19 Research (19 papers), Animal Virus Infections Studies (8 papers) and Viral Infections and Vectors (8 papers). Entao Li is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), Animal Virus Infections Studies (8 papers) and Viral Infections and Vectors (8 papers). Entao Li collaborates with scholars based in China, South Korea and Czechia. Entao Li's co-authors include Yuanliang Hu, Deyun Wang, Youying Li, Cui Liu, Zhenzhen Gao, Sandra Chiu, Jiaguo Liu, Yi Wu, Xiuping Li and Xianzhu Xia and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Entao Li

50 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Entao Li China 15 247 185 181 120 105 54 742
Sepideh Shahbazi Iran 12 362 1.5× 123 0.7× 78 0.4× 117 1.0× 171 1.6× 17 989
Hongli Jin China 19 294 1.2× 329 1.8× 92 0.5× 135 1.1× 42 0.4× 72 929
José Carlos de Magalhães Brazil 15 156 0.6× 174 0.9× 139 0.8× 82 0.7× 59 0.6× 50 745
Cybele C. Garcı́a Argentina 23 319 1.3× 418 2.3× 153 0.8× 143 1.2× 141 1.3× 62 1.2k
Yolanda Corbett Italy 16 325 1.3× 78 0.4× 119 0.7× 108 0.9× 223 2.1× 29 1.2k
Anuja Krishnan India 16 312 1.3× 329 1.8× 92 0.5× 160 1.3× 64 0.6× 34 955
Zeenathul Nazariah Allaudin Malaysia 17 268 1.1× 109 0.6× 58 0.3× 101 0.8× 60 0.6× 52 805
Syed Shahzad‐ul‐Hussan Pakistan 16 269 1.1× 147 0.8× 78 0.4× 66 0.6× 52 0.5× 29 592
Regina Ching Hua Lee Singapore 18 200 0.8× 255 1.4× 100 0.6× 71 0.6× 102 1.0× 30 790
Yudong Cui China 16 375 1.5× 178 1.0× 51 0.3× 99 0.8× 170 1.6× 78 843

Countries citing papers authored by Entao Li

Since Specialization
Citations

This map shows the geographic impact of Entao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Entao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Entao Li more than expected).

Fields of papers citing papers by Entao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Entao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Entao Li. The network helps show where Entao Li may publish in the future.

Co-authorship network of co-authors of Entao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Entao Li. A scholar is included among the top collaborators of Entao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Entao Li. Entao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ren, Yi, Pengfei Fan, Ting Fang, et al.. (2025). Potent Cross‐neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein. Advanced Science. 12(27). e2501996–e2501996. 1 indexed citations
3.
Li, Entao, Qiyuan Yang, Wenyu Xie, et al.. (2025). An mpox quadrivalent mRNA vaccine elicits sustained and protective immunity in mice against lethal vaccinia virus challenge. Emerging Microbes & Infections. 14(1). 2447619–2447619. 2 indexed citations
4.
Huang, Lei, Fanfan Zhao, Muye He, et al.. (2024). An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants. Journal of Controlled Release. 366. 479–493. 12 indexed citations
5.
Li, Ming, Yao Zhong, Entao Li, et al.. (2024). An adenosine analog shows high antiviral potency against coronavirus and arenavirus mainly through an unusual base pairing mode. Nature Communications. 15(1). 10750–10750. 2 indexed citations
6.
Wu, Yi, Xiaoying Jia, Xinghai Zhang, et al.. (2024). Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants. Acta Pharmaceutica Sinica B. 15(2). 947–962.
7.
Chen, Shaohong, Xinghai Zhang, Yanfeng Yao, et al.. (2024). Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. Virologica Sinica. 39(6). 909–916. 5 indexed citations
8.
Zhang, Huajun, Yanfeng Yao, Ming Li, et al.. (2024). Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains. Nature Communications. 15(1). 2987–2987. 13 indexed citations
9.
Zheng, Tong, Yu Bai, Entao Li, et al.. (2024). The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association. Journal of Virology. 98(4). e0156523–e0156523. 2 indexed citations
10.
Zhou, Jinge, Kaiyue Zhang, Yuping Wang, et al.. (2024). Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Reports. 43(6). 114269–114269. 20 indexed citations
11.
Zhou, Jinge, Yun Yang, Entao Li, et al.. (2024). Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Molecular Therapy. 32(6). 1779–1789. 37 indexed citations
12.
Li, Entao, Xiaoping Guo, Wenyu Xie, et al.. (2023). Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Signal Transduction and Targeted Therapy. 8(1). 350–350. 27 indexed citations
13.
Zeng, Weihong, Xiaoying Jia, Xiangyang Chi, et al.. (2023). An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants. International Journal of Biological Macromolecules. 253(Pt 3). 126817–126817. 7 indexed citations
14.
Zhang, Cheng, Huan Cui, Entao Li, et al.. (2022). The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice. Frontiers in Immunology. 13. 869809–869809. 14 indexed citations
15.
Wang, Ningning, Entao Li, Lei Zhou, et al.. (2022). Inosine: A broad-spectrum anti-inflammatory against SARS-CoV-2 infection-induced acute lung injury via suppressing TBK1 phosphorylation. Journal of Pharmaceutical Analysis. 13(1). 11–23. 10 indexed citations
16.
Yan, Feihu, Entao Li, Tiecheng Wang, et al.. (2022). Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19. Frontiers in Immunology. 13. 821664–821664. 36 indexed citations
17.
Huang, Pei, Yue Yu, Tiecheng Wang, et al.. (2021). Development of recombinase polymerase amplification assays for rapid and visual detection of canine distemper virus infecting giant panda. BMC Veterinary Research. 17(1). 172–172. 2 indexed citations
18.
Liu, Cui, Jin Chen, Entao Li, et al.. (2015). Solomonseal Polysaccharide and Sulfated Codonopsis pilosula Polysaccharide Synergistically Resist Newcastle Disease Virus. PLoS ONE. 10(2). e0117916–e0117916. 12 indexed citations
19.
Wu, Yi, Youying Li, Chang Liu, et al.. (2015). Structural characterization of an acidic Epimedium polysaccharide and its immune-enhancement activity. Carbohydrate Polymers. 138. 134–142. 55 indexed citations
20.
Liu, Cui, Entao Li, Deyun Wang, et al.. (2014). The comparison of antioxidative and hepatoprotective activities of Codonopsis pilosula polysaccharide (CP) and sulfated CP. International Immunopharmacology. 24(2). 299–305. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026